IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,675 | -39.2% | 11,050 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $30,719 | +52.7% | 11,050 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $20,111 | -64.1% | 11,050 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $56,024 | +5.7% | 11,050 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $53,000 | +32.5% | 10,750 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $40,000 | -32.2% | 10,750 | +2.9% | 0.00% | -50.0% |
| Q1 2022 | $59,000 | – | 10,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 226,916 | $383,488 | 0.76% |
| HARBOURVEST PARTNERS LLC | 335,709 | $567,348 | 0.19% |
| ALLEN HOLDING INC /NY | 687,571 | $1,161,995 | 0.16% |
| ARMISTICE CAPITAL, LLC | 3,476,000 | $5,874,440 | 0.09% |
| Clearwater Capital Advisors, LLC | 394,599 | $666,873 | 0.08% |
| SHEETS SMITH WEALTH MANAGEMENT | 273,879 | $462,856 | 0.07% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $162,972 | 0.06% |
| WEALTH EFFECTS LLC | 53,500 | $90,415 | 0.04% |
| Virtus ETF Advisers LLC | 34,461 | $58,239 | 0.04% |
| FISHMAN JAY A LTD/MI | 162,000 | $273,780 | 0.04% |